EyePoint, Inc. (EYPT) intrinsic value & 10-year financials
EyePoint, Inc. (EYPT) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 39.0% a year to $31.4M, with an average return on invested capital of -73.7%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $2.99
- Market cap
- $219.0K
- Revenue (FY2025)
- $31.4M
- Revenue growth (10-yr CAGR)
- 39.0%
- ROIC (10-yr avg)
- -73.7%
- Free cash flow (FY2025)
- -$243.4M
EYPT 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $31.4M | -$232.0M | -$3.17 | -$243.4M | -776.0% | -100.7% |
| FY2024 | $43.3M | -$130.9M | -$2.32 | -$130.3M | -337.1% | -117.3% |
| FY2023 | $46.0M | -$70.8M | -$1.82 | -$1.6M | -163.1% | -411.7% |
| FY2022 | $41.4M | -$102.3M | -$2.74 | -$67.2M | -240.6% | -219.6% |
| FY2021 | $36.9M | -$58.4M | -$2.03 | -$50.3M | -149.6% | -189.8% |
| FY2020 | $34.4M | -$45.4M | — | -$14.8M | -108.3% | -148.4% |
| FY2019 | $20.4M | -$56.8M | — | -$56.9M | -235.0% | -361.8% |
| FY2018 | $3.0M | -$53.2M | — | -$22.0M | -887.3% | 393.9% |
| FY2017 | $7.5M | -$18.5M | -$0.52 | -$20.6M | -246.4% | 521.5% |
| FY2016 | $1.6M | -$21.5M | -$0.68 | -$16.4M | -1344.1% | -103.5% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
EyePoint, Inc. is a consistent compounder, expanding top-line revenue at 39.0% annually over the past decade.
EyePoint, Inc. has historically struggled to out-earn its cost of capital, averaging just -47.3% ROIC.
Over the decade, EyePoint, Inc. shows that management has aggressively returned capital to shareholders by retiring 99.8% of outstanding shares.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, EyePoint, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-105.29 per share.